Stimulexin en es it fr

Stimulexin Brand names, Stimulexin Analogs

Stimulexin Brand Names Mixture

  • No information avaliable

Stimulexin Chemical_Formula


Stimulexin RX_link

Stimulexin fda sheet

Stimulexin FDA

Stimulexin msds (material safety sheet)

Stimulexin MSDS

Stimulexin Synthesis Reference

No information avaliable

Stimulexin Molecular Weight

378.507 g/mol

Stimulexin Melting Point

No information avaliable

Stimulexin H2O Solubility

Sparingly soluble

Stimulexin State


Stimulexin LogP


Stimulexin Dosage Forms

Liquid; Solution

Stimulexin Indication

For use as a temporary measure in hospitalized patients with acute respiratory insufficiency superimposed on chronic obstructive pulmonary disease.

Stimulexin Pharmacology

Doxapram is an analeptic agent (a stimulant of the central nervous system). The respiratory stimulant action is manifested by an increase in tidal volume associated with a slight increase in respiratory rate. A pressor response may result following doxapram administration. Provided there is no impairment of cardiac function, the pressor effect is more marked in hypovolemic than in normovolemic states. The pressor response is due to the improved cardiac output rather than peripheral vasoconstriction. Following doxapram administration, an increased release of catecholamines has been noted.

Stimulexin Absorption

No information avaliable

Stimulexin side effects and Toxicity

Intravenous LD50 values in the mouse and rat were approximately 75 mg/kg and in the cat and dog were 40 to 80 mg/kg. Symptoms of overdosage are extensions of the pharmacologic effects of the drug. Excessive pressor effect, tachycardia, skeletal muscle hyperactivity, and enhanced deep tendon reflexes may be early signs of overdosage.

Stimulexin Patient Information

No information avaliable

Stimulexin Organisms Affected

Humans and other mammals